» Articles » PMID: 8584039

An Electrophysiological Investigation of the Effects of Cisplatin and the Protective Actions of Dexamethasone on Cultured Dorsal Root Ganglion Neurones from Neonatal Rats

Overview
Specialty Pharmacology
Date 1995 Sep 1
PMID 8584039
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

In this study we have investigated the acute and chronic effects of cisplatin on whole cell currents in cultured dorsal root ganglion neurones. Consistent with effects on action potentials measured under current clamp, acute (5 min) application of cisplatin (5 microM) attenuated voltage-activated potassium, and mixed cation currents by approximately 50% in both cases. Chronic treatment (5-7 days) of cultured neurones with 5 microM cisplatin also resulted in greatly reduced voltage-activated potassium currents (by 50%) and calcium currents (by 60%) compared to events recorded from neurones not treated with cisplatin. In contrast, the amplitude of inward cation current activated by hyperpolarization was doubled by 5-12 days treatment with cisplatin. Studies on action potential after-depolarizations and calcium-activated chloride currents suggest that cisplatin disturbs calcium homeostatic mechanisms. These observations may account for anode break spike excitation and the low efficiency with which cells buffer intracellular calcium following cisplatin treatment. Dexamethasone has been found to enhance the anti-emetic effects of 5-HT3 receptor antagonists in patients treated with cisplatin. For this reason the actions of dexamethasone were studied in combination with cisplatin treatment. Although acute application of dexamethasone (1-10 microM) produced transient depolarizations and bursts of action potentials, after 5 minutes application it had no effect on membrane potential, input resistance, or the properties of action potentials evoked by depolarizing current commands.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

Preferential Cochleotoxicity of Cisplatin.

Prayuenyong P, Baguley D, Kros C, Steyger P Front Neurosci. 2021; 15:695268.

PMID: 34381329 PMC: 8350121. DOI: 10.3389/fnins.2021.695268.


Gastric myoelectric activity during cisplatin-induced acute and delayed emesis reveals a temporal impairment of slow waves in ferrets: effects not reversed by the GLP-1 receptor antagonist, exendin (9-39).

Lu Z, Ngan M, Lin G, Yew D, Fan X, Andrews P Oncotarget. 2017; 8(58):98691-98707.

PMID: 29228720 PMC: 5716760. DOI: 10.18632/oncotarget.21859.


Specific hemosiderin deposition in spleen induced by a low dose of cisplatin: altered iron metabolism and its implication as an acute hemosiderin formation model.

Wang Y, Juan L, Ma X, Wang D, Ma H, Chang Y Curr Drug Metab. 2010; 11(6):507-15.

PMID: 20540689 PMC: 2910113. DOI: 10.2174/138920010791636149.

References
1.
Aggarwal S . A histochemical approach to the mechanism of action of cisplatin and its analogues. J Histochem Cytochem. 1993; 41(7):1053-73. DOI: 10.1177/41.7.8515048. View

2.
Hamill O, Marty A, Neher E, Sakmann B, Sigworth F . Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 1981; 391(2):85-100. DOI: 10.1007/BF00656997. View

3.
Yarker Y, McTavish D . Granisetron. An update of its therapeutic use in nausea and vomiting induced by antineoplastic therapy. Drugs. 1994; 48(5):761-93. DOI: 10.2165/00003495-199448050-00008. View

4.
Woods A, Andrews P . Cisplatin acutely reduces 5-hydroxytryptamine-induced vagal depolarization in the rat: protective action of dexamethasone. Eur J Pharmacol. 1995; 278(3):275-8. DOI: 10.1016/0014-2999(95)00174-j. View

5.
Milne R, Heel R . Ondansetron. Therapeutic use as an antiemetic. Drugs. 1991; 41(4):574-95. DOI: 10.2165/00003495-199141040-00006. View